Advances In Triple Negative Breast Cancer Treatment

Advances In Triple Negative Breast Cancer Treatment

>>>Dr. Margileth: Triple negative breast cancer is defined as a breast cancer that is estrogen receptor negative, progesterone receptor negative, and HER2-neu-gene negative. What this implies is that hormone therapies such as aromatase inhibitors or tamoxifen would have no effect in the treatment of that cancer and Herceptin, which is used in HER2 positive breast […]

Continue reading